Legal Opinion
Abbvie Inc. v. Medimmune Limited
Court of Appeals for the Federal Circuit
Decided February 5, 2018No. 2017-1689PublishedCited by 2 opinions
1Opinion of the Court
Dyk, Circuit Judge.
AbbVie, Inc., and AbbVie Biotechnology Ltd. (“AbbVie”) filed suit in the Eastern District of Virginia against Medlmmune Limited (“Medlmmune”), seeking a declaratory judgment that U.S. Patent No. 6,248,516 (“the ’516 patent”) is invalid. The district court determined that it lacked jurisdiction under the Declaratory Judgment Act, 28 U.S.C. §§ 2201-02, and alternatively that it would not exercise jurisdiction if it existed, and it granted Medlmmune’s motion to dismiss. We affirm.
Background
This declaratory-judgment action concerns a development and licensing agreement entered…
2Cases cited17 opinions
- Aetna Life Insurance v. HaworthSupreme Court of the United States · 1937
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- Skelly Oil Co. v. Phillips Petroleum Co.Supreme Court of the United States · 1950
- Public Serv. Comm'n of Utah v. Wycoff Co.Supreme Court of the United States · 1952
- United States v. LovettSupreme Court of the United States · 1946
12 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Aids Healthcare Foundation v. Gilead Sciences, Inc.Court of Appeals for the Federal Circuit · 2018
- Therese Harmon, Trustee of the Harmon 1999 Descendants' Trust v. HarmonDistrict Court, E.D. Virginia · 2023